Dressler syndrome (literature review)
V.V. BLINOVA, T.M. BOGDANOVA, V.A. SEMENOVA, E.O. SERGEEVA, M.A. ZANKIN, M.S. SINKEEV
Saratov State Medical University, Saratov
Contact details:
Blinova V.V. — PhD (medicine), Associate Professor of the Department of Propaedeutics of Internal Diseases
Address: 112 Bolshaya Kazachya St., Saratov, Russian Federation, 410012, tel.: 8-906-302-45-94, e-mail: blinowa.viky@yandex.ru, ORCID ID 0000-0002-2367-736X
The purpose is to present a literature review on a rather rare pathology — Dressler syndrome, paying special attention to one of its main components — pericarditis.
Material and methods. Russian and foreign literature on Dressler syndrome were studied, with special attention to the sources over the recent 10 years.
Results. A review of the medical literature on the topic — Dressler syndrome is presented, describing the concept, etio-pathogenetic aspects, classification, epidemiology, a brief historical background, clinical picture, laboratory and instrumental features, and tactics of patient management.
Conclusion. Dressler syndrome is understood as a symptom complex that occurs due to myocardial damage of various genesis with the development of autoimmune aggression and subsequent hyperergic reaction with benign lesion of serous membranes, leading to the appearance of pericarditis, pleurisy, pneumonitis and other symptoms. The initial clinical manifestations and the subsequent course of this syndrome, as a rule, are often unexpressed. Therefore, a timely assessment of clinical and instrumental data that go beyond the usual course of the post-infarction / postoperative period, as well as the effect of the therapy used, contributes to the timely diagnosis of this syndrome and, accordingly, the appointment of adequate pathogenetic therapy.
Key words: Dressler syndrome, post-infarction syndrome, pericarditis, Doppler echocardiography.
(For citation: Blinova V.V., Bogdanova T.M., Semenova V.A., Sergeeva E.O., Zankin M.A., Sinkeev M.S. Dressler syndrome (literature review). Practical medicine. 2023. Vol. , № , P.)
REFERENCES
- Glushchenko V.A., Irklienko E.K. Cardiovascular morbidity is one of the most important healthcare problems. Meditsina i organizatsiya zdravookhraneniya, 2019, vol. 4, no. 1, pp. 56–60 (in Russ.).
- Bokeriya L.A. Current trends in the development of cardiovascular surgery (20 years later). Annaly khirurgii, 2016, no. 21, pp. 10–18 (in Russ.).
- Shaldybin P.D., Matveeva E.S., Davydov I.V. Cardiac surgery from its inception to the present day. Vestnik Soveta molodykh uchenykh i spetsialistov Chelyabinskoy oblasti, 2018, no. 3, pp. 40–45 (in Russ.).
- Shaldybin P.D., Zlakomanova O.N., Davydov I.V. Heart transplantation is a problem of our time. Vestnik Soveta molodykh uchenykh i spetsialistov Chelyabinskoy oblasti, 2018, no. 3, pp. 46–50 (in Russ.).
- Igol’nikova L.N., Nikulina E.G. Postpericardiotomy syndrome: clinical and laboratory diagnosis, treatment (literature review). Kardiologiya i serdechno-sosudistaya khirurgiya, 2012, no. 5 (1), pp. 42–46 (in Russ.).
- Spodick D.H. Post-myocardial infarction syndrome (Dressler’s syndrome). Am Coll Cardiol J Rev, 1995, vol. 4, rr. 35–37.
- Meurin P., Weher H., Renaud N. et al. Evolution of the postoperative pericardial effusion after day 15: the problem of the late tamponade. Chest, 2004, vol. 125 (6), rr. 2182–2187.
- Soloff L.A., Zatuchni J., Janton O.H. et al. Rheumatic Fever Following Mitral Commissurotomy. Circulation, 1953, vol. 8, rr. 481–493.
- Dressler W. A postmyocardial infarction syndrome; preliminary report of a complication resembling idiopathic, recurrent, benign pericarditis. Journal of the American Medical Association, 1956, vol. 160 (16), pp. 1379–1383.
- Yamani N., Abbasi A., Almas T. et al. Diagnosis, treatment, and management of pericardial effusion- review. Ann Med Surg (Lond), 2022, vol. 9 (80), pp. 104–142. DOI: 10.1016/j.amsu.2022.104142
- Aouifi A., Piriou V., Blanc P. et al. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anaesth, 1999, vol. 83 (4), rr. 602–607.
- Vasil’ev G.A. Procalcitonin is a new indicator in the diagnosis of severe infection (biochemistry, physiological properties, definition, comparison with other indicators). Ukrainskiy meditsinskiy zhurnal, 2001, no. 4, pp. 129–138 (in Russ.).
- Imazio M., Demichelis B., Cecchi E. et al. Cardiac troponin I in acute pericarditis. J Am Coll Cardiol, 2003, vol. 42 (12), pp. 2144–2148.
- O’Gara P.T., Kushner F.G., Ascheim D.D. et al. A Report of the American College of Cardiology Foundation. American Heart Association Task Force on Practice Guidelines. J Amer Coll Cardiol, 2013, vol. 61 (4), rr. 78–140.
- Murashko V.V., Strutynskiy A.V. Elektrokardiografiya: uchebn. posobie. 17-e izd. [Electrocardiography: textbook. allowance. 17th ed.]. Moscow: MEDpress-inform, 2021. 360 p.
- Gentry J., Klein A.L., Gellis C.L. Transient Constrictive Pericarditis: Current Diagnostic and Therapeutic Strategies. Curr Cardiol Rep, 2016, vol. 18 (5), r. 41.
- Shiller N.B., Osipov M.A. Klinicheskaya ekhokardiografiya. 2-e izd. [Clinical echocardiography. 2nd ed.]. Moscow: MEDpress inform, 2018. 344 p.
- Adler Y., Charron P., Imazio M. et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J, 2015, vol. 36, rr. 2921–2964. DOI: 10.1093/eurheartj/ehv318
- Maggiolini S., De Carlini C.C., Ferri L.A. et al. The role of early contrast-enhanced chest computed tomography in the aetiological diagnosis of patients presenting with cardiac tamponade or large pericardial effusion. Eur Heart J Cardiovasc Imaging, 2016, vol. 36. 17 (4), rr. 421–428. DOI: 10.1093/ehjci/jev225
- Pericarditis. Clinical recommendations 2022. Rossiyskiy kardiologicheskiy zhurnal, 2023, no. 28 (3), pp. 107–166 (in Russ.).
- Mager A., Berger D., Ofek H. et al. Prodromal symptoms predict myocardial involvement in patients with acute idiopathic pericarditis. Int J Cardiol, 2018, vol. 270, rr. 197–199. DOI: 10.1016/j.ijcard.2018.05.128
- Mauro A., Mezzaroma E., Torrado J. et al. A novel Nlrp3 inflammasome inhibitor prevents acute pericarditis in an experimental mouse model. Circulation, 2016, vol. 134 (1), p. A15152.
- Galluzzo A., Imazio M. Advances in medical therapy for pericardial diseases. Expert Rev Cardiovasc Ther, 2018, vol. 16 (9), rr. 635–643. DOI: 10.1080/14779072.2018.1510315
- Imazio M., Gaita F. Diagnosis and treatment of pericarditis. Heart, 2015, vol. 101 (14), pp. 1159–1168. DOI: 10.1136/heartjnl-2014-306362
- Imazio M., Gaita F. Acute and recurrent pericarditis. Cardiol Clin, 2017, vol. 35 (4), rr. 505–513. DOI: 10.1016/j.ccl.2017.07.004
- Cremer P.C., Kumar A., Kontzias A. et al. Complicated pericarditis understanding risk factors and pathophysiology to inform imaging and treatment. Journal of the American College of Cardiology, 2016, vol. 68, rr. 2311–2328.
- Smilde B.J., Woudstra L., Fong Hing G. et al. Colchicine aggravates coxsackievirus B3 infection in mice. Int J Cardiol, 2016, vol. 216, rr. 58–65.
- Cantinotti M., Spadoni I., Assanta N. et al. Controversies in the prophylaxis and treatment of postsurgical pericardial syndromes: a critical review with a special emphasis on paediatric age. J Cardiovasc Med (Hagerstown), 2014, vol. 15 (12), rr. 847–854. DOI: 10.2459/JCM.0b013e328362c5b5
- Imazio M., Belli R., Brucato A. et al. Rationale and design of the Colchicine for Prevention of the Postpericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 trial): a randomized, placebo-controlled, multicenter study on the use of colchicine for the primary prevention of the postpericardiotomy syndrome, postoperative effusions, and postoperative atrial fibrillation. Amer Heart J, 2013, vol. 166 (1), rr. 13–19.